Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

DepewTube: Early Start for Biotech


Markets, movers and more.

Executive editor Kevin Depew offers his take on the Apple (AAPL) iPhone -- hell yes, he'd buy one -- and notes that the big story is the price cut on top of additional features.

Kevin takes a hard look at the biotech sector and specifically the iShares Nasdaq Biotech Index ETF (IBB). The normal seasonal run for biotech typically begins in August, but we're seeing some demand creep in a smidge earlier this year.

On days like this it's important to look at relative strength - those sectors and stocks outperforming the market, even if that outperformance is simply a case of not dipping as much as the market. Those are the areas that rebound first.

< Previous
  • 1
Next >
No positions in stocks mentioned.

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.

Featured Videos